APLSApellis Pharmaceuticals Inc
APLS
Apellis Pharmaceuticals Inc3,802
Mkt Cap
$2.18BVolume
90.69M52W High
$30.4852W Low
$16.10PE Ratio
138.38APLS Fundamentals
Price
$40.23Prev Close
$17.09Open
$40.4050D MA
$20.68Beta
1.05Avg. Volume
2.17MEPS (Annual)
$0.1724P/B
5.85Rev/Employee
$1.36M$3,268.56
Best Mid Cap Stocks To Watch Today - March 31st
ProShares UltraPro Short QQQ, Apellis Pharmaceuticals, Centessa Pharmaceuticals, Applied Optoelectronics, and Direxion Daily TSLA Bull 2X Shares are the five Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid-cap stocks are shares of companies with market capitalizati...
MarketBeat·3h ago
Noteworthy Tuesday Option Activity: APLS, AMTM, EXP
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Apellis Pharmaceuticals Inc (Symbol: APLS), where a total volume of 23,358 contracts has been traded thus far today, a contract volume which is representative of...
Nasdaq News: Markets·3h ago
Pharmaceutical Stocks To Watch Today - March 31st
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Eli Lilly and Company, AbbVie, Pfizer, Abbott Laboratories, and Novo Nordisk A/S are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that r...
MarketBeat·4h ago
Medical Stocks To Add to Your Watchlist - March 31st
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Eli Lilly and Company, UnitedHealth Group, Boston Scientific, AbbVie, and Pfizer are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of companies involved in healthcare including p...
MarketBeat·4h ago
Apellis Pharmaceuticals (NASDAQ:APLS) Receives "Hold" Rating from Needham & Company LLC
Needham & Company LLC reissued a "hold" rating on shares of Apellis Pharmaceuticals in a research note on Tuesday...
MarketBeat·4h ago
Shareholder Alert: The Ademi Firm investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Apellis...
PR Newswire·7h ago
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders? Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 31, 2026 Insiders may stand to receive...
PR Newswire·7h ago
Apellis Pharmaceuticals (NASDAQ:APLS) Sets New 1-Year High - Here's Why
Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 1-Year High - Time to Buy...
MarketBeat·8h ago
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen for $41/share. Other gainers incl. Centessa, Annexon, Agios, Fulcrum, Scholar Rock, Alkermes, Wave...
Benzinga·9h ago
Futures Jump On Hopes Of War De-escalation, Korea Enters Bear Market On Memory Rout
Futures Jump On Hopes Of War De-escalation, Korea Enters Bear Market On Memory Rout
Futures are higher on a WSJ report that Trump is considering exiting the middle east conflict even if the Strait of Hormuz is not reopened; but the market is deciding whether this is a genuine intent to...
Zero Hedge·10h ago
<
1
2
...
>